about
Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cellsQuantitative proteome analysis of plasma microparticles for the characterization of HCV-induced hepatic cirrhosis and hepatocellular carcinoma.Motile hepatocellular carcinoma cells preferentially secret sugar metabolism regulatory proteins via exosomes.Mitochondrial DNA-enriched microparticles promote acute-on-chronic alcoholic neutrophilia and hepatotoxicityRole of circulating microRNAs in liver diseasesExtracellular vesicles in liver pathobiology: Small particles with big impact.Exosomal miRNAs as biomarkers in the diagnosis of liver disease.New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD).Mechanisms of cholangiocyte responses to injury.The role of the secretin/secretin receptor axis in inflammatory cholangiocyte communication via extracellular vesicles.MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis.Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate CellsThe diagnostic/prognostic potential and molecular functions of long non-coding RNAs in the exosomes derived from the bile of human cholangiocarcinomaVps4A-mediated tumor suppression upon exosome modulation?RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines.lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma.Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition.Exosome-Mimetic Nanovesicles from Hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo.Hepatic stellate cell-derived PDGFRα-enriched extracellular vesicles promote liver fibrosis in mice through SHP2.Extracellular vesicles as therapeutic carriers of microRNAs for cholangiocarcinoma.The challenge of cholangiocarcinoma diagnosis: The turning point is in extracellular vesicles?miR-93-5p-Containing Exosomes Treatment Attenuates Acute Myocardial Infarction-Induced Myocardial Damage.Extracellular vesicles in liver disease and beyondCytosolic nucleic acid sensors of the innate immune system promote liver regeneration after partial hepatectomy
P2860
Q33807881-5A78621B-E9DB-4A28-83A9-CD1A2AE870EFQ38375370-1D8FE09A-B2F6-4DAF-8BA3-BDC9B6102E7CQ38432667-154809DE-3472-4C99-8780-3DAB46527FB2Q38671413-723D5707-7461-4635-AFC0-2EB8222CE360Q38779843-716FE1A1-CFFE-4CB5-BCCE-F36A222AE701Q38954563-B932D399-C563-407C-B2AE-C05C4BA7725EQ39361895-82AA93FB-9278-42EE-BC7A-0F596DE220C6Q39393326-3CA4F689-FFC7-494A-83A2-902F864C3A53Q39397552-3F2C1FE2-EEC9-4B24-A07E-7FBE08F536C6Q40052358-D07101D9-EE88-4A58-9DC3-F865001D0980Q40198585-C030DCF5-4154-4786-9605-875F7D711636Q40375820-D6377CDA-7403-4E18-B2F3-3024486C73A8Q42378400-D8702AAC-3EA7-4109-A2EE-19BC47F5F2C6Q42770182-AFF63E43-50DB-4DA7-BE19-08704AD6B7E6Q45664343-F24B344C-B53E-44F2-A553-F48E00031380Q47234281-90A59C40-2EA4-4D05-9DD5-B574C54608C4Q47768810-5CE3BDB4-8834-4771-B0BE-5BC3AC3DC686Q48096026-A283FDCA-99BC-4616-A17C-D2FB0C5AEAFDQ48185795-84CFCBA8-4593-4029-BC45-3D5623293BEDQ49237863-2C7715BA-50D7-4551-BFA2-5CD5722F7EE4Q52765918-0D823AB0-538B-4795-B78D-CE4FD3B7DD41Q54975644-838DD78A-AED4-4BC4-BC54-A44C0503EB8AQ58602200-76437D6B-E259-4D97-8DFB-FF95CE8AB0AFQ58774511-C969BB4D-145B-43ED-9D43-B204882DC7B0
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Exosomes in liver pathology.
@en
type
label
Exosomes in liver pathology.
@en
prefLabel
Exosomes in liver pathology.
@en
P2093
P2860
P1476
Exosomes in liver pathology.
@en
P2093
Fanyin Meng
Gianfranco Alpini
Keisaku Sato
Shannon Glaser
P2860
P304
P356
10.1016/J.JHEP.2016.03.004
P577
2016-03-14T00:00:00Z